KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Repurchased
Ratios

Pacira BioSciences (PCRX) Shares Outstanding (2016 - 2023)

Historic Shares Outstanding for Pacira BioSciences (PCRX) over the last 15 years, with Q3 2023 value amounting to $46.4 million.

  • Pacira BioSciences' Shares Outstanding rose 122.75% to $46.4 million in Q3 2023 from the same period last year, while for Sep 2023 it was $46.4 million, marking a year-over-year increase of 122.75%. This contributed to the annual value of $45.9 million for FY2022, which is 266.91% up from last year.
  • According to the latest figures from Q3 2023, Pacira BioSciences' Shares Outstanding is $46.4 million, which was up 122.75% from $46.4 million recorded in Q2 2023.
  • Pacira BioSciences' 5-year Shares Outstanding high stood at $46.4 million for Q3 2023, and its period low was $41.3 million during Q1 2019.
  • Over the past 5 years, Pacira BioSciences' median Shares Outstanding value was $44.4 million (recorded in 2021), while the average stood at $44.1 million.
  • Per our database at Business Quant, Pacira BioSciences' Shares Outstanding skyrocketed by 437.12% in 2021 and then soared by 122.75% in 2023.
  • Over the past 5 years, Pacira BioSciences' Shares Outstanding (Quarter) stood at $41.9 million in 2019, then grew by 4.13% to $43.6 million in 2020, then rose by 2.51% to $44.7 million in 2021, then rose by 2.67% to $45.9 million in 2022, then rose by 1.09% to $46.4 million in 2023.
  • Its Shares Outstanding was $46.4 million in Q3 2023, compared to $46.4 million in Q2 2023 and $46.0 million in Q1 2023.